Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$4.6 - $7.95 $970,599 - $1.68 Million
211,000 Added 143.15%
358,400 $1.65 Million
Q2 2023

Aug 14, 2023

BUY
$5.66 - $7.59 $370,730 - $497,145
65,500 Added 79.98%
147,400 $952,000
Q1 2023

May 15, 2023

SELL
$7.31 - $11.18 $532,899 - $815,022
-72,900 Reduced 47.09%
81,900 $617,000
Q4 2022

Feb 14, 2023

SELL
$9.48 - $14.52 $643,692 - $985,908
-67,900 Reduced 30.49%
154,800 $1.57 Million
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $776,479 - $1.15 Million
84,400 Added 61.03%
222,700 $2.2 Million
Q2 2022

Aug 15, 2022

BUY
$5.72 - $10.65 $82,368 - $153,360
14,400 Added 11.62%
138,300 $1.47 Million
Q1 2022

May 16, 2022

BUY
$7.46 - $14.14 $924,294 - $1.75 Million
123,900 New
123,900 $1.21 Million
Q4 2021

Feb 14, 2022

SELL
$12.99 - $17.73 $747,444 - $1.02 Million
-57,540 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$14.85 - $21.34 $854,469 - $1.23 Million
57,540 New
57,540 $1.15 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.